| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 121.46B | 115.36B | 122.13B | 116.62B | 103.03B |
| Gross Profit | 30.26B | 25.42B | 25.98B | 26.58B | 23.45B |
| EBITDA | 13.72B | 11.75B | 13.40B | 15.80B | 11.48B |
| Net Income | 6.39B | 5.00B | 6.29B | 7.71B | 5.01B |
Balance Sheet | |||||
| Total Assets | 128.11B | 119.73B | 118.01B | 114.65B | 99.70B |
| Cash, Cash Equivalents and Short-Term Investments | 30.31B | 30.93B | 25.23B | 33.16B | 29.40B |
| Total Debt | 1.04B | 1.11B | 2.09B | 3.53B | 4.93B |
| Total Liabilities | 46.77B | 43.36B | 43.63B | 43.50B | 35.87B |
| Stockholders Equity | 71.92B | 67.63B | 65.80B | 63.05B | 56.28B |
Cash Flow | |||||
| Free Cash Flow | 2.81B | 9.41B | 219.00M | 6.07B | 636.00M |
| Operating Cash Flow | 6.42B | 13.54B | 5.70B | 9.26B | 3.25B |
| Investing Cash Flow | -4.00B | -2.91B | -2.41B | -6.65B | -1.97B |
| Financing Cash Flow | -3.01B | -4.94B | -6.20B | -3.85B | -4.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥79.63B | 9.87 | ― | 3.28% | 5.28% | 28.90% | |
76 Outperform | ¥160.18B | 14.15 | ― | 2.30% | 13.82% | 37.07% | |
75 Outperform | ¥153.08B | 10.80 | 11.52% | 2.76% | 4.00% | 38.72% | |
70 Outperform | ¥58.97B | 606.48 | ― | 0.28% | 8.64% | -23.20% | |
66 Neutral | ¥181.68B | 15.39 | 18.89% | 2.78% | 11.90% | 60.66% | |
65 Neutral | ¥32.65B | 10.11 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
Mitsubishi Research Institute reported a strong rebound in earnings for the quarter ended December 31, 2025, with net sales rising 11.5% year on year to ¥30.9 billion and profit attributable to owners of parent surging 165.6% to ¥2.63 billion, driving basic earnings per share up to ¥167.27. The company also strengthened its financial position, as the equity-to-asset ratio improved to 59.0%, while it kept its full-year forecasts for the fiscal year ending September 30, 2026 unchanged, projecting essentially flat net sales and a modest decline in profits, and reaffirmed plans to maintain the annual dividend at ¥165 per share, signaling stability for shareholders despite expectations of lower profitability ahead.
The most recent analyst rating on (JP:3636) stock is a Buy with a Yen5341.00 price target. To see the full list of analyst forecasts on Mitsubishi Research Institute stock, see the JP:3636 Stock Forecast page.